ROBAFEN COUGH FORMULA

Product NDC
0904-0061
11-digit product format
009040061
Labeler code
0904
Product ID
0904-0061_93c5eb05-cf18-4dda-e053-2a95a90a874f
Type
HUMAN OTC DRUG
Nonproprietary name
Guaifenesin
Dosage form
SYRUP
Route
ORAL
Labeler
Major Pharmaceuticals
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2012-08-15
Marketing end
2020-09-30
Substance
GUAIFENESIN
Active strength
100 mg/5mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 8 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0904-0061DDiscontinued by firm2026-10-05
excluded productproduct0904-0061DDiscontinued by firm2026-10-05
excluded productproduct0904-0061DDiscontinued by firm2026-10-05
excluded packagepackage0904-00610904-0061-00DDiscontinued by firm2026-10-05
excluded packagepackage0904-00610904-0061-09DDiscontinued by firm2026-10-05
excluded packagepackage0904-00610904-0061-16DDiscontinued by firm2026-10-05
excluded packagepackage0904-00610904-0061-20DDiscontinued by firm2026-10-05
excluded packagepackage0904-00610904-0061-20DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 96 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0904-0061-16d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0904-0061-20d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0904-0061-00d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0904-0061-09d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0904-0061-20d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0904-0061-16f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0904-0061-20f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0904-0061-00f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0904-0061-09f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0904-0061-20f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0904-0061-162ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0904-0061-202ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0904-0061-002ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0904-0061-092ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0904-0061-202ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0904-0061-16a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0904-0061-20a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0904-0061-00a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0904-0061-09a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0904-0061-20a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0904-0061-16cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0904-0061-20cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0904-0061-00cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0904-0061-09cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0904-0061-20cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0904-0061-16cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0904-0061-20cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0904-0061-00cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0904-0061-09cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0904-0061-20cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0904-0061-16302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0904-0061-20302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0904-0061-00302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0904-0061-09302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0904-0061-20302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage0904-0061-16ed331223b511…672a5bd82f5f…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4fe95224-f543-4dbb-9445-8cca122b48c8Product name120150609
e8718272-64cb-4436-969b-176c3067c8f4Product name120150609
106ff02a-57e1-4c4c-a307-fd582ff4e311Product name120150212

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0904-0061-00ML - Milliliter0904-0061ab74a419-4d6e-4e23-9a99-1f393c107cc212013-08-02
0904-0061-09ML - Milliliter0904-006170451862-9fed-4bf4-b236-a2f6f9fab1fd12012-07-24
0904-0061-16ML - Milliliter0904-00615cef9570-dca3-44fb-9657-497b3992742212013-08-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
GuaifenesinACTIVE INGREDIENT495W7451VQROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
GuaifenesinACTIVE MOIETY495W7451VQROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
Anhydrous Citric AcidINACTIVE INGREDIENTXF417D3PSLROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
CaramelINACTIVE INGREDIENTT9D99G2B1RROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
Corn SyrupINACTIVE INGREDIENT9G5L16BK6NROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
FD&C Red no. 40INACTIVE INGREDIENTWZB9127XOAROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
GlycerinINACTIVE INGREDIENTPDC6A3C0OXROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
MentholINACTIVE INGREDIENTL7T10EIP3AROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
Propylene GlycolINACTIVE INGREDIENT6DC9Q167V3ROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
Saccharin SodiumINACTIVE INGREDIENTSB8ZUX40TYROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
Sodium BenzoateINACTIVE INGREDIENTOJ245FE5EUROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
WaterINACTIVE INGREDIENT059QF0KO0RROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [MAJOR PHARMACEUTICALS]2
GUAIFENESINACTIVE INGREDIENT495W7451VQROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1
GUAIFENESINACTIVE MOIETY495W7451VQROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSLROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1
CARAMELINACTIVE INGREDIENTT9D99G2B1RROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1
CORN SYRUPINACTIVE INGREDIENT9G5L16BK6NROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1
MENTHOLINACTIVE INGREDIENTL7T10EIP3AROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3ROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1
SACCHARIN SODIUMINACTIVE INGREDIENTSB8ZUX40TYROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1
WATERINACTIVE INGREDIENT059QF0KO0RROBAFEN COUGH FORMULA (GUAIFENESIN) SYRUP [AIDAREX PHARMACEUTICALS LLC]1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310604guaiFENesin 100 MG in 5 mL Oral SolutionPSNf73e1db1-cd54-4e1e-a739-4be0d73ac4a62
213155Robafen 200 MG in 10 mL Oral SolutionPSNf73e1db1-cd54-4e1e-a739-4be0d73ac4a62
213155guaifenesin 20 MG/ML Oral Solution [Robafen]SBDf73e1db1-cd54-4e1e-a739-4be0d73ac4a62
310604guaifenesin 20 MG/ML Oral SolutionSCDf73e1db1-cd54-4e1e-a739-4be0d73ac4a62
310604guaifenesin 100 MG per 5 ML Oral SolutionSYf73e1db1-cd54-4e1e-a739-4be0d73ac4a62
310604guaifenesin 100 MG per 5 ML Oral SyrupSYf73e1db1-cd54-4e1e-a739-4be0d73ac4a62
310604guaifenesin 200 MG per 10 ML Oral SolutionSYf73e1db1-cd54-4e1e-a739-4be0d73ac4a62
310604guaifenesin 300 MG per 15 ML Oral SolutionSYf73e1db1-cd54-4e1e-a739-4be0d73ac4a62
310604guaifenesin 400 MG per 20 ML Oral SolutionSYf73e1db1-cd54-4e1e-a739-4be0d73ac4a62
213155Robafen 100 MG per 5 mL Oral SolutionSYf73e1db1-cd54-4e1e-a739-4be0d73ac4a62
213155Robafen 200 MG per 10 mL Oral SolutionSYf73e1db1-cd54-4e1e-a739-4be0d73ac4a62
310604guaiFENesin 100 MG in 5 mL Oral SolutionPSNa925e169-a63d-4614-925e-e556daef9ec51
213155Robafen 200 MG in 10 mL Oral SolutionPSNa925e169-a63d-4614-925e-e556daef9ec51
213155guaifenesin 20 MG/ML Oral Solution [Robafen]SBDa925e169-a63d-4614-925e-e556daef9ec51
310604guaifenesin 20 MG/ML Oral SolutionSCDa925e169-a63d-4614-925e-e556daef9ec51
310604guaifenesin 100 MG per 5 ML Oral SolutionSYa925e169-a63d-4614-925e-e556daef9ec51
310604guaifenesin 100 MG per 5 ML Oral SyrupSYa925e169-a63d-4614-925e-e556daef9ec51
310604guaifenesin 200 MG per 10 ML Oral SolutionSYa925e169-a63d-4614-925e-e556daef9ec51
310604guaifenesin 300 MG per 15 ML Oral SolutionSYa925e169-a63d-4614-925e-e556daef9ec51
310604guaifenesin 400 MG per 20 ML Oral SolutionSYa925e169-a63d-4614-925e-e556daef9ec51
213155Robafen 100 MG per 5 mL Oral SolutionSYa925e169-a63d-4614-925e-e556daef9ec51
213155Robafen 200 MG per 10 mL Oral SolutionSYa925e169-a63d-4614-925e-e556daef9ec51